Wolf I - Search Results

1

Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis.

Goldman O, Adler LN, Hajaj E, Croese T, Darzi N, Galai S, Tishler H, Ariav Y, Lavie D, Fellus-Alyagor L, Oren R, Kuznetsov Y, David E, Jaschek R, Stossel C, Singer O, Malitsky S, Barak R, Seger R, Erez N, Amit I, Tanay A, Saada A, Golan T, Rubinek T, Sang Lee J, Ben-Shachar S, Wolf I, Erez A. Goldman O, et al. Among authors: wolf i. Cancer Discov. 2023 Jul 7;13(7):1616-1635. doi: 10.1158/2159-8290.CD-22-1062. Cancer Discov. 2023. PMID: 36972357 Free PMC article.

2

KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer.

Abramovitz L, Rubinek T, Ligumsky H, Bose S, Barshack I, Avivi C, Kaufman B, Wolf I. Abramovitz L, et al. Among authors: wolf i. Clin Cancer Res. 2011 Jul 1;17(13):4254-66. doi: 10.1158/1078-0432.CCR-10-2749. Epub 2011 May 13. Clin Cancer Res. 2011. PMID: 21571866

3

The Role of Alpha-Klotho as a Universal Tumor Suppressor.

Rubinek T, Wolf I. Rubinek T, et al. Among authors: wolf i. Vitam Horm. 2016;101:197-214. doi: 10.1016/bs.vh.2016.03.001. Epub 2016 Apr 6. Vitam Horm. 2016. PMID: 27125743 Review.

4

Role of Klotho Protein in Tumor Genesis, Cancer Progression, and Prognosis in Patients with High-Grade Glioma.

Peshes-Yeloz N, Ungar L, Wohl A, Jacoby E, Fisher T, Leitner M, Nass D, Rubinek T, Wolf I, Cohen ZR. Peshes-Yeloz N, et al. Among authors: wolf i. World Neurosurg. 2019 Oct;130:e324-e332. doi: 10.1016/j.wneu.2019.06.082. Epub 2019 Jun 20. World Neurosurg. 2019. PMID: 31228703

5

Less Is More: Polypharmacy at the End of Life.

Barak R, Waissengrin B, Wolf I. Barak R, et al. Among authors: wolf i. Isr Med Assoc J. 2021 Jul;23(7):452-453. Isr Med Assoc J. 2021. PMID: 34251131 Free article. No abstract available.

6

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT, Tai HH, Karlan BY, Koeffler HP. Wolf I, et al. Cancer Res. 2006 Aug 1;66(15):7818-23. doi: 10.1158/0008-5472.CAN-05-4368. Cancer Res. 2006. PMID: 16885386

7

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study.

Wolf I, Ben-Baruch N, Shapira-Frommer R, Rizel S, Goldberg H, Yaal-Hahoshen N, Klein B, Geffen DB, Kaufman B. Wolf I, et al. Cancer. 2008 Feb 15;112(4):731-6. doi: 10.1002/cncr.23225. Cancer. 2008. PMID: 18076012 Free article.

8

Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.

Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP, Rubinek T. Wolf I, et al. Oncogene. 2008 Nov 27;27(56):7094-105. doi: 10.1038/onc.2008.292. Epub 2008 Sep 1. Oncogene. 2008. PMID: 18762812

9

Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.

Wolf I, Laitman Y, Rubinek T, Abramovitz L, Novikov I, Beeri R, Kuro-O M, Koeffler HP, Catane R, Freedman LS, Levy-Lahad E, Karlan BY, Friedman E, Kaufman B. Wolf I, et al. Oncogene. 2010 Jan 7;29(1):26-33. doi: 10.1038/onc.2009.301. Epub 2009 Oct 5. Oncogene. 2010. PMID: 19802015

10

Cetuximab in metastatic colorectal cancer.

Wolf I, Golan T, Shani A, Aderka D. Wolf I, et al. Lancet Oncol. 2010 Apr;11(4):313-4; author reply 314. doi: 10.1016/S1470-2045(10)70019-X. Lancet Oncol. 2010. PMID: 20359660 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

585 results

Search Page